Brazil
# |
Name |
Free Cash Flow |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 210.94 M
|
Dec. 31, 2023 | USD 2.04 | 0.87% |
|
Brazil |
|
2 |
USD 164.19 M
|
Dec. 31, 2023 | USD 16.15 | -4.10% |
|
Brazil |
|
3 |
USD 21.72 M
|
Dec. 31, 2023 | USD 2.21 | -0.40% |
|
Brazil |
|
4 |
USD 4.15 M
|
Dec. 31, 2023 | USD 1.97 | 2.04% |
|
Brazil |
|
5 |
USD 2.22 M
|
Dec. 31, 2023 | USD 1.95 | -3.23% |
|
Brazil |
|
6 |
USD -16.66 M
|
Dec. 31, 2023 | USD 1.66 | 0.01% |
|
Brazil |
|
7 |
USD -365.09 M
|
Dec. 31, 2023 | USD 0.31 | -1.64% |
|
Brazil |
|
8 |
USD -478.39 M
|
Dec. 31, 2023 | USD 4.80 | 0.53% |
|
Brazil |
The Biotechnology company in Brazil with the highest Free Cash Flow is Fleury S.A. (São Paulo Stock Exchange: FLRY3.SA) at USD 210.94 M.
The Biotechnology company in Brazil with the lowest Free Cash Flow is Rede D'Or São Luiz S.A. (São Paulo Stock Exchange: RDOR3.SA) at USD -478.39 M.
The top 10 Biotechnology companies in Brazil by Free Cash Flow are Fleury S.A., Afya Limited, Blau Farmacêutica S.A., Baumer S.A., Centro de Imagem Diagnósticos S.A., Biomm S.A., Diagnósticos da América S.A. and Rede D'Or São Luiz S.A..
The bottom 10 Biotechnology companies in Brazil by Free Cash Flow are Rede D'Or São Luiz S.A., Diagnósticos da América S.A., Biomm S.A., Centro de Imagem Diagnósticos S.A., Baumer S.A., Blau Farmacêutica S.A., Afya Limited and Fleury S.A..